Position in TBPH
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$2,656,915
+$1,736,875 QoQ
Shares Held
163,704
+99.6% QoQ
Ownership
0.318%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TBPH Over Time
Shares Held
Position Value (USD)
Derivatives in TBPH
reported options exposure · as of Mar 31, 2026CallValue
$0
CallShares
0
PutValue
$4,036,401
PutShares
248,700
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026Caption Management, LLC holds $170,916,514 across 70 Biotechnology names. TBPH ranks #17 (1.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CGON |
CG Oncology, Inc.
|
378,480 | $25,615,526 | |
| 2 | IMCR |
Immunocore Holdings plc
|
661,786 | $19,952,847 | |
| 3 | CYTK |
Cytokinetics Inc
|
245,000 | $16,147,950 | |
| 4 | ELVN |
Enliven Therapeutics, Inc.
|
370,000 | $14,504,000 | |
| 5 | CORT |
Corcept Therapeutics Inc
|
260,000 | $10,480,600 | |
| 6 | HRMY |
Harmony Biosciences Holdings, Inc.
|
272,292 | $7,626,898 | |
| 7 | AVTX |
Avalo Therapeutics, Inc.
|
455,000 | $6,793,150 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
219,800 | $6,088,460 |
All Filings in TBPH
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,036,401 | 248,700 | Put | Sole | 2026-05-15 | |
| 2026-03-31 | $2,656,915 | 163,704 | Shares | Sole | 2026-05-15 | |
| 2022-12-31 | $920,040 | 82,000 | Shares | Sole | 2023-02-14 | |
| 2022-12-31 | $2,244,000 | 200,000 | Call | Sole | 2023-02-14 | |
| 2022-12-31 | $561,000 | 50,000 | Put | Sole | 2023-02-14 | |
| 2022-09-30 | $608,400 | 60,000 | Put | Sole | 2022-11-14 | |
| 2022-09-30 | $2,129,400 | 210,000 | Call | Sole | 2022-11-14 | |
| 2022-09-30 | $608,400 | 60,000 | Shares | Sole | 2022-11-14 | |
| 2022-03-31 | $143,400 | 15,000 | Call | Sole | 2022-05-13 | |
| 2022-03-31 | $304,008 | 31,800 | Shares | Sole | 2022-05-13 | |
| 2022-03-31 | $605,148 | 63,300 | Put | Sole | 2022-05-13 | |
| 2021-06-30 | $217,800 | 15,000 | Put | Sole | 2021-08-16 | |
| 2021-06-30 | $217,800 | 15,000 | Call | Sole | 2021-08-16 | |
| 2021-03-31 | $612,300 | 30,000 | Call | Sole | 2021-05-17 | |
| 2021-03-31 | $612,300 | 30,000 | Put | Sole | 2021-05-17 | |
| 2020-09-30 | $65,054 | 4,400 | Shares | Sole | 2020-11-16 | |
| 2020-09-30 | $443,550 | 30,000 | Put | Sole | 2020-11-16 | |
| 2020-09-30 | $443,550 | 30,000 | Call | Sole | 2020-11-16 | |
| 2020-06-30 | $134,692 | 6,417 | Shares | Sole | 2020-08-14 | |
| 2020-06-30 | $440,790 | 21,000 | Put | Sole | 2020-08-14 | |
| 2020-03-31 | $288,875 | 12,500 | Put | Sole | 2020-05-15 | |
| 2020-03-31 | $288,875 | 12,500 | Call | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||